Cargando…

Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2‐overexpressing tumor

Fibroblast growth factor receptor (FGFR) is associated with proliferation, migration, and angiogenesis of carcinomas, and FGFR signaling inhibitors are considered a key drug for the treatment of solid tumors with FGFR overexpression. Amplification of FGFR2 is reportedly identified in 3%‐10% of gastr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuroda, Kenji, Yashiro, Masakazu, Miki, Yuichiro, Sera, Tomohiro, Yamamoto, Yurie, Sugimoto, Atsushi, Nishimura, Sadaaki, Kushiyama, Shuhei, Togano, Shingo, Okuno, Tomohisa, Ohira, Masaichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734156/ https://www.ncbi.nlm.nih.gov/pubmed/32946655 http://dx.doi.org/10.1111/cas.14654

Ejemplares similares

Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer
por: Yashiro, Masakazu, et al.
Publicado: (2021)

Gastric cancer stem cells survive in stress environments via their autophagy system
por: Togano, Shingo, et al.
Publicado: (2021)

Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer
por: Togano, Shingo, et al.
Publicado: (2020)

Correction: Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer
por: Togano, Shingo, et al.
Publicado: (2020)

Establishment of a gastric cancer cell line with high microsatellite instability, OCUM‐13, derived from Borrmann type‐2 primary tumor
por: Yamamoto, Yurie, et al.
Publicado: (2022)

CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma
por: Yamamoto, Yurie, et al.
Publicado: (2022)

Lipocalin-2 negatively regulates epithelial–mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer
por: Nishimura, Sadaaki, et al.
Publicado: (2022)

The clinicopathological significance of Thrombospondin-4 expression in the tumor microenvironment of gastric cancer
por: Kuroda, Kenji, et al.
Publicado: (2019)

Circulating CEA‐positive and EpCAM‐negative tumor cells might be a predictive biomarker for recurrence in patients with gastric cancer
por: Miki, Yuichiro, et al.
Publicado: (2020)

SDF1α/CXCR4 axis may be associated with the malignant progression of gastric cancer in the hypoxic tumor microenvironment
por: Yashiro, Masakazu, et al.
Publicado: (2021)

The clinicopathologic significance of Tks5 expression of peritoneal mesothelial cells in gastric cancer patients
por: Sugimoto, Atsushi, et al.
Publicado: (2021)

Clinicopathologic significance of TROP2 and phospho-TROP2 in gastric cancer
por: Kushiyama, Shuhei, et al.
Publicado: (2021)

Clinico-pathological significance of exosome marker CD63 expression on cancer cells and stromal cells in gastric cancer
por: Miki, Yuichiro, et al.
Publicado: (2018)

Clinical benefit for clinical sequencing using cancer panel testing
por: Nishimura, Sadaaki, et al.
Publicado: (2021)

CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells
por: Miki, Yuichiro, et al.
Publicado: (2018)

Significance of tumor heterogeneity of p-Smad2 and c-Met in HER2-positive gastric carcinoma with lymph node metastasis
por: Tsujio, Gen, et al.
Publicado: (2022)

Pyruvate kinase isozyme M2 and glutaminase might be promising molecular targets for the treatment of gastric cancer
por: Kitayama, Kishu, et al.
Publicado: (2017)

Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors
por: Javle, Milind, et al.
Publicado: (2023)

Crosstalk Between Cancer Associated Fibroblasts and Cancer Cells in Scirrhous Type Gastric Cancer
por: Miki, Yuichiro, et al.
Publicado: (2020)

FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro
por: Künstlinger, Helen, et al.
Publicado: (2015)

Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment
por: Ruan, Ruiwen, et al.
Publicado: (2023)

FGFR families: biological functions and therapeutic interventions in tumors
por: Liu, Qing, et al.
Publicado: (2023)

Growth charts in FGFR2- and FGFR3-related faciocraniosynostoses
por: Ea, Caroline, et al.
Publicado: (2022)

Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer
por: Facchinetti, Francesco, et al.
Publicado: (2023)

Novel mutation detection of fibroblast growth factor receptor 1 (FGFR1) gene, FGFR2IIIa, FGFR2IIIb, FGFR2IIIc, FGFR3, FGFR4 gene for craniosynostosis: A prospective study in Asian Indian patient
por: Barik, Mayadhar, et al.
Publicado: (2015)

FGFR- gene family alterations in low-grade neuroepithelial tumors
por: Bale, Tejus A.
Publicado: (2020)

The Emerging Role of the FGF/FGFR Pathway in Gastrointestinal Stromal Tumor
por: Astolfi, Annalisa, et al.
Publicado: (2020)

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2020)

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
por: Weickhardt, Andrew J., et al.
Publicado: (2022)

Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer
por: Lazo De La Vega, Lorena, et al.
Publicado: (2022)

Runx2 is required for the proliferation of osteoblast progenitors and induces proliferation by regulating Fgfr2 and Fgfr3
por: Kawane, Tetsuya, et al.
Publicado: (2018)

Neutrophils in primary gastric tumors are correlated with neutrophil infiltration in tumor-draining lymph nodes and the systemic inflammatory response
por: Hiramatsu, Soichiro, et al.
Publicado: (2018)

Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer
por: Wang, Cong, et al.
Publicado: (2019)

The Evaluation of FGFR1, FGFR2 and FOXO1 in Orofacial Cleft Tissue
por: Goida, Jana, et al.
Publicado: (2022)

FGFR redundancy limits the efficacy of FGFR4-selective inhibitors in hepatocellular carcinoma
por: Tao, Zhanchao, et al.
Publicado: (2022)

Oncogenic FGFR1 mutation and amplification in common cellular origin in a composite tumor with neuroblastoma and pheochromocytoma
por: Tasaka, Keiji, et al.
Publicado: (2022)

Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer
por: Jogo, Tomoko, et al.
Publicado: (2021)

Prognostic impact of postoperative systemic inflammatory response in patients with stage II/III gastric cancer
por: Kuroda, Kenji, et al.
Publicado: (2022)

FGFR3 has tumor suppressor properties in cells with epithelial phenotype
por: Lafitte, Marie, et al.
Publicado: (2013)

FGFR3-TACC3 fusion in solid tumors: mini review
por: Costa, Ricardo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rh36q7i9t309fojgp6b2tsuu8a